Welcome to our dedicated page for Paysign news (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on Paysign stock.
Paysign, Inc. reports developments in patient affordability programs, donor compensation solutions, engagement and management platforms, and integrated payment processing for the life sciences industries. The company operates at the intersection of fintech and healthcare, serving plasma, pharmaceutical and life sciences customers with payment and program-management technologies.
Recurring updates cover earnings results, patient affordability growth, pharmaceutical copay program performance, claims-processing activity, plasma donor compensation revenue, and SaaS engagement technologies for donor and program management. Company announcements also discuss Dynamic Business Rules for mitigating copay accumulators and maximizers, physical, virtual, mobile and bank-based payment capabilities, reporting and analytics, and investor conference participation.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Paysign, Inc. (NASDAQ: PAYS) announced its participation at the Ladenburg Thalmann Technology Expo in location value="LU/us.ny.nyc"New York City on April 27, 2023, at 2:30 p.m. EDT. The Expo will showcase management presentations from around 50 technology firms, covering various sectors such as media, software, and hardware.
Paysign, headquartered in Henderson, Nevada, specializes in prepaid card programs and integrated payment services, enhancing operational efficiency for clients in diverse industries, including healthcare and retail.
Investors interested in attending can contact the Expo organizers via email at techexpo@ladenburg.com.